Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2015 | 12-2014 | 12-2013 | 12-2012 | 08-2012 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 158,407 | 151,175 | 83,552 | 36,476 | 23,749 |
Marketable Securities | N/A | N/A | N/A | 22,096 | 15,307 |
Receivables | 13,267 | 7,455 | 6,181 | N/A | N/A |
Inventories | 6,424 | 9,134 | 3,000 | 0 | N/A |
TOTAL | $181,399 | $171,605 | $96,299 | $60,182 | $42,167 |
Non-Current Assets | |||||
PPE Net | 7,644 | 5,880 | 1,810 | 416 | 403 |
Intangibles | 228,686 | 6,249 | 6,488 | 5,431 | 5,480 |
Other Non-Current Assets | 5,619 | 5,332 | 4,129 | 2,094 | 239 |
TOTAL | $241,949 | $17,461 | $12,427 | $7,941 | $6,122 |
Total Assets | $423,348 | $189,066 | $108,726 | $68,123 | $48,289 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 5,423 | 2,550 | 5,264 | 4,599 | 1,601 |
Accrued Expenses | 22,630 | 16,859 | 13,128 | 2,150 | 2,652 |
Other current liabilities | N/A | 711 | 7,066 | 16,405 | 17,266 |
TOTAL | $40,053 | $29,120 | $30,156 | $23,168 | $21,541 |
Non-Current Liabilities | |||||
Long Term Debt | 39,000 | 51,000 | 50,000 | 25,000 | N/A |
Deferred Revenues | N/A | N/A | 4,698 | 6 | 14 |
Other Non-Current Liabilities | 226,800 | 60,000 | 0 | 0 | 0 |
TOTAL | $266,103 | $111,000 | $50,000 | $25,011 | $13 |
Total Liabilities | $306,156 | $140,120 | $80,156 | $48,179 | $21,554 |
Shareholders' Equity | |||||
Shares Outstanding, K | 85,244 | 69,144 | 62,479 | 53,507 | N/A |
Common Shares | 85 | 69 | 62 | 52 | 51 |
Retained earnings | -323,117 | -257,895 | -205,355 | -135,938 | -116,646 |
Other shareholders' equity | -1,377 | -60 | -383 | -115 | -50 |
TOTAL | $117,192 | $48,946 | $28,570 | $19,944 | $26,735 |
Total Liabilities And Equity | $423,348 | $189,066 | $108,726 | $68,123 | $48,289 |